adult RSV prevention

Advertisement

cGxPJobs Banner

GSK RSV Vaccine Arexvy Gains FDA Approval for Adults 18–49

LONDON, United Kingdom, March 13, 2026 Global biopharmaceutical company GSK has announced that the U.S. Food and Drug Administration...

By cGxPwire Editor
March 16, 2026

Read More

Advertisement

cGxPJobs

Directory